MY103790A - Novel compound for the treatment of several bone affecting diseases - Google Patents

Novel compound for the treatment of several bone affecting diseases

Info

Publication number
MY103790A
MY103790A MYPI88001227A MYPI19881227A MY103790A MY 103790 A MY103790 A MY 103790A MY PI88001227 A MYPI88001227 A MY PI88001227A MY PI19881227 A MYPI19881227 A MY PI19881227A MY 103790 A MY103790 A MY 103790A
Authority
MY
Malaysia
Prior art keywords
treatment
novel compound
several bone
affecting diseases
bone affecting
Prior art date
Application number
MYPI88001227A
Inventor
Bjorn Wallmark
Per Lindberg
Rolf Hakanson
Kalervo Vaananen
Original Assignee
Ab Hassle
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from SE8704247A external-priority patent/SE8704247D0/en
Priority claimed from SE8704436A external-priority patent/SE8704436D0/en
Application filed by Ab Hassle filed Critical Ab Hassle
Publication of MY103790A publication Critical patent/MY103790A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nutrition Science (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

THERE IS DISCLOSED A COMPOUND OF THE FORMULA 1@@(FORMULA. 1)@@OR A PRODRUG OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, FOR THE TREATMENT OF OSTEOPOROSIS, PAGET'S DISEASE OF BONE, HYPERPARATHYROIDISM, MALIGNANT NEOPLASMS CAUSING HYPERCALCINEMIA, PARODONTAL DISEASES AND IMPLANT-RELATED BONE LOSS AND FOR USE IN THE MANUFACTURE OF MEDICAMENTS FOR SUCH TREATMENTS.
MYPI88001227A 1987-10-30 1988-10-27 Novel compound for the treatment of several bone affecting diseases MY103790A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE8704247A SE8704247D0 (en) 1987-10-30 1987-10-30 METHOD OF TREATMENT
SE8704436A SE8704436D0 (en) 1987-11-13 1987-11-13 USE OF ANTI-SECRETARY SUBSTANCES FOR NEW INDICATIONS

Publications (1)

Publication Number Publication Date
MY103790A true MY103790A (en) 1993-09-30

Family

ID=26660006

Family Applications (1)

Application Number Title Priority Date Filing Date
MYPI88001227A MY103790A (en) 1987-10-30 1988-10-27 Novel compound for the treatment of several bone affecting diseases

Country Status (9)

Country Link
EP (1) EP0338066A1 (en)
JP (1) JPH02501930A (en)
KR (1) KR890701580A (en)
AU (1) AU2621888A (en)
DK (1) DK322289D0 (en)
HU (1) HU886738D0 (en)
IL (2) IL88207A (en)
MY (1) MY103790A (en)
WO (2) WO1989003830A1 (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8804628D0 (en) * 1988-12-22 1988-12-22 Ab Haessle NEW COMPOUNDS
JP2694361B2 (en) * 1989-02-09 1997-12-24 アストラ アクチエボラグ Antibacterial agent
US5081253A (en) * 1989-12-21 1992-01-14 American Home Products Corporation Imidazo(4,5-c)pyridines as antiosteoporotic agents
PL165898B1 (en) * 1990-06-20 1995-02-28 Astra Ab Method of obtaining novel derivatives of dialkoxy pyridinyl benzimidazole
SE9002206D0 (en) * 1990-06-20 1990-06-20 Haessle Ab NEW COMPOUNDS
WO1997048694A1 (en) * 1996-06-20 1997-12-24 Board Of Regents, The University Of Texas System Compounds and methods for providing pharmacologically active preparations and uses thereof
US6316020B1 (en) * 1999-08-26 2001-11-13 Robert R. Whittle Pharmaceutical formulations
DE10040052A1 (en) * 2000-08-11 2002-03-07 Univ Eberhard Karls Use of proton pump inhibitors for the treatment of inflammation, in particular diseases of the musculoskeletal system
KR100453916B1 (en) * 2002-03-11 2004-10-20 주식회사 코오롱 Tetrahydropyridinylbenzimidazole derivatives and method for preparing the same
GB0403165D0 (en) * 2004-02-12 2004-03-17 Ct Novel uses for proton pump inhibitors
KR100638649B1 (en) 2006-06-27 2006-10-31 신한전기공업주식회사 Dry type transformer having insulation reinforcement
CN103826632B (en) * 2011-08-26 2017-04-12 国立大学法人名古屋大学 Osteogenesis promoter and use thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE416649B (en) * 1974-05-16 1981-01-26 Haessle Ab PROCEDURE FOR THE PREPARATION OF SUBSTANCES WHICH PREVENT Gastric acid secretion
US4472409A (en) * 1981-11-05 1984-09-18 Byk Gulden Lomberg Chemische Fabrik Gesellschaft Mit Beschrankter Haftung 2-Pyridylmethyl thio(sulfinyl)benzimidazoles with gastric acid secretion inhibiting effects
SE8500996D0 (en) * 1985-03-01 1985-03-01 Haessle Ab METHOD OF TREATMENT

Also Published As

Publication number Publication date
DK322289A (en) 1989-06-28
KR890701580A (en) 1989-12-21
IL88207A0 (en) 1989-06-30
DK322289D0 (en) 1989-06-28
WO1989003829A1 (en) 1989-05-05
WO1989003830A1 (en) 1989-05-05
EP0338066A1 (en) 1989-10-25
IL88206A0 (en) 1989-06-30
HU886738D0 (en) 1990-02-28
AU2621888A (en) 1989-05-23
JPH02501930A (en) 1990-06-28
IL88207A (en) 1993-03-15

Similar Documents

Publication Publication Date Title
SE8704248D0 (en) MEDICAL USE
GR3007251T3 (en)
AU1808488A (en) Compounds for the treatment of alzheimer's disease
SG45315A1 (en) Improvements in or relating to benzothiopenes
BR9609063A (en) Dinucleotides useful for the treatment of lung diseases
GR3019388T3 (en) The use of buspirone for preparing a pharmaceutical composition for the treatment of alcohol abuse
MY103790A (en) Novel compound for the treatment of several bone affecting diseases
AU1790988A (en) Phosphoethanolamine for treatment of alzheimer's disease
FI884553A0 (en) Analogous Process for the Preparation of Therapeutically Useful 9-Aminotetrahydroacridine Derivatives
EP1069125A3 (en) Carbamate derivatives of 4-amino-3-isoxazolidinones, 3-amino-1-hydroxypyrrolidin-2-ones and 1-amino-1-cyclopropanecarboxylic acid analogs, a process for their preparation and their use as medicaments
EP0269311A3 (en) Methods of treating bone diseases by administration of a cysteine proteinase inhibitor
EP0342587A3 (en) Thienotriazolodiazepine compounds and pharmaceutical uses thereof
IL134263A0 (en) Use of phanquinone for the treatment of alzheimer's disease
EP0328924A3 (en) Thienotriazolodiazepine compounds and pharmaceutical uses thereof
HUT50325A (en) Process for producing bisphenylalkyl piperazine derivatives and pharmaceutical compositions comprising same as active ingredient
SE8704436D0 (en) USE OF ANTI-SECRETARY SUBSTANCES FOR NEW INDICATIONS
PT99864A (en) METHOD FOR PREPARING NEW PHARMACEUTICAL COMPOSITIONS CONTAINING QUISQUALATE RECEPTOR ANTAGONISTS
HK1012572A1 (en) Pyridylbishopsphonates for use as a therapeutical agent
EP0437929A3 (en) Use of diadenosine-5',5'''-p1,p4-tetraphosphate for the manufacture of a medicament for the treatment of heart disease
IL101163A (en) Use of flunarizine in the preparation of medicaments for treating neoplastic diseases
HU9203052D0 (en) Method for treatment of hypertension
EP0784973A3 (en) Quinoxaline derivatives for treating tinnitus
CA2033975A1 (en) Use of .beta.-receptor blocking agents
NZ226237A (en) Choline diethyl-dithiocarbamate, process for the preparation thereof, and medicaments
IL86647A (en) Pharmaceutical composition comprising 6-(1-imidazolylmethyl)-5,6,7,8-tetrahydronaphthalene-2-carboxylic acid